Analysed Kalvista Pharmaceuticals Inc (KALV:NASDAQ) News Sources
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance
KalVista Pharmaceuticals Presents New Data Highlighting High Patient Satisfaction and Evolving Treatment Trends with EKTERLY® (sebetralstat)
Yahoo Finance
Analysts Offer Insights on Healthcare Companies: Kymera Therapeutics (KYMR) and Amylyx Pharmaceuticals Inc (AMLX)
The Globe and Mail
Analysts Are Bullish on These Healthcare Stocks: Rhythm Pharmaceuticals (RYTM), BeOne Medicines (ONC)
The Globe and Mail
Novel Drug Navenibart for Hereditary Angioedema So Far Safe, Effective With Quarterly Dosing
Medscape
What is the current price of Kalvista Pharmaceuticals Inc (KALV:NASDAQ)?
The current price of Kalvista Pharmaceuticals Inc (KALV:NASDAQ) is $16.23.
Kalvista Pharmaceuticals Inc (KALV:NASDAQ) absolute price change since previous trading day?
The absolute price change of Kalvista Pharmaceuticals Inc (KALV:NASDAQ) since the previous trading day is $0.02.
Kalvista Pharmaceuticals Inc (KALV:NASDAQ) percentage price change since previous trading day?
The percentage price change of Kalvista Pharmaceuticals Inc (KALV:NASDAQ) since the previous trading day is 0.12%.
What is This Week's average sentiment score for Kalvista Pharmaceuticals Inc (KALV:NASDAQ)?
This Week's average sentiment score for Kalvista Pharmaceuticals Inc (KALV:NASDAQ) is 80 out of 100.
What is This Week's average sentiment for Kalvista Pharmaceuticals Inc (KALV:NASDAQ)?
This Week's sentiment for Kalvista Pharmaceuticals Inc (KALV:NASDAQ) is .
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.